Exogenous spermine inhibits the proliferation of human pulmonary artery smooth muscle cells caused by chemically-induced hypoxia via the suppression of the ERK1/2- and PI3K/AKT-associated pathways.

Pulmonary vascular remodeling is a significant pathological feature of hypoxia-induced pulmonary hypertension (HPH), while pulmonary artery smooth muscle cell (PASMC) proliferation plays a leading role in pulmonary vascular remodeling. Spermine (Sp), a polyamine, plays a critical role in periodic cell proliferation and apoptosis. The present study was conducted to observe the association between hypoxia-induced PASMC proliferation and polyamine metabolism, and to explore the effects of exogenous Sp on PASMC poliferation and the related mechanisms. In the present study, PASMCs were cultured with cobalt chloride (CoCl2) to establish a hypoxia model, and Sp at various final concentrations (0.1, 1, 10 and 100 µM) was added to the medium of PASMCs 40 min prior to the induction of hypoxia. Cell proliferation was measured by 3-(4,5-dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide (MTT) assay, cell counting kit-8 assay and 5-bromo‑2'‑deoxyuridine (BrdU) incorporation assay. Cell cycle progression was determined by flow cytometry, and the protein expression levels of spermidine/spermine N1-acetyltransferase (SSAT; the key enzyme in the terminal degradation of polyamine), ornithine decarboxylase (ODC; the key enzyme of polyamine biosynthesis), cyclin D1 and p27 were measured by western blot analysis. The results revealed that the proliferation of the PASMCs cultured with CoCl2 at 50 µM for 24 h markedly increased. The expression of ODC was decreased and the expression of SSAT was increased in the cells under hypoxic conditions. Exogenous Sp at concentrations of 1 and 10 µM significantly inhibited hypoxia-induced PASMC proliferation, leading to cell cycle arrest at the G1/G0 phase. In addition, Sp decreased cyclin D1 expression, increased p27 expression, and suppressed the phosphorylation of extracellular signal‑regulated kinase 1/2 (ERK1/2), phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT); however, the above-metioned parameters were not markedly affected by Sp at concentrations of 0.1 or 100 µM. These results suggest that hypoxia disrupts polyamine metabolism, and Sp at concentrations of 1 and 10 µM inhibits the increase in human PASMC proliferation caused by chemically-induced hypoxia via the suppression of the ERK1/2- and PI3K/AKT-associated pathways. This study thus offer new insight into the prevention and treatment of HPH.

Introduction

Chronic hypoxia-induced pulmonary hypertension (HPH), an incurable disease, is often a complication in patients with chronic heart failure, chronic obstructive pulmonary disease and sleep apnea (1). Pulmonary arterial remodeling, a marker of severe and advanced HPH, is primarily attributed to the abnormal proliferation of pulmonary artery smooth muscle cells (PASMCs) (2,3). Thus, the inhibition of the aberrant proliferation of PASMCs may prove to be a novel therapeutic strategy for the treatment of HPH.

Cyclin D1 and its associated cyclin-dependent kinases (CDKs) are regulated proteins which are key in controlling the re-entry of quiescent cells from the G0 to the G1 phase (4). p27 blocks the G1-S transition in the cell cycle, and is a negative regulator of the protein kinases, cyclin/CDK (5). The interaction of the two factors regulates cell proliferation and apoptosis (6). The activity of extracellular signal-regulated kinase 1/2 (ERK1/2), a major mitogenic signaling pathway, has been shown to be significantly enhanced in a variety of animal models of pulmonary arterial hypertension (7). Previous studies have revealed that 5-hydroxytryptamine (5-HT) and platelet-derived growth factor (PDGF) induce the proliferation of PASMCs through the activation of the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) signaling pathways (8,9). Therefore, blocking these signaling pathways may play a key role in the prevention and treatment of HPH.

Spermine (Sp), a polyamine, is a non-protein small molecule with polyvalent positive charges and nitrogen. Polyamine homeostasis is of great importance for cell survival (10). Ornithine decarboxylase (ODC) is the key enzyme of polyamine biosynthesis, and spermidine/spermine N1-acetyltransferase (SSAT) is the key enzyme in the terminal degradation of polyamides. They are both associated with the regulation of polyamine metabolism (11). However, to the best of our knowledge, the role which Sp plays in PASMC proliferation has not yet been elucidated. Cobalt chloride (CoCl2) is a well-known hypoxia-mimetic agent that mimics the hypoxic response in many aspects (12). Therefore, in the present study, we established a hypoxia model by culturing PASMCs with CoCl2, and then observed the changes in polyamine metabolism following hypoxia. In addition, we examined the effects of exogenous Sp on PASMC proliferation and the underlying mechanisms.

Materials and methods

Materials

Sp was purchased from Sigma-Aldrich (St. Louis, MO, USA). 5-Bromo-2′-deoxyuridine (BrdU) Labeling reagent and the Detection Kit I were obtained from Roche Diagnostics GmbH (Mannheim, Germany). Anti-cyclin D1 and anti-p27 antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-mitogen-activated protein kinase (MAPK), anti-PI3K p85 and anti-AKT antibodies were all purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Alkaline phosphatase-labeled goat anti-rabbit IgG antibody and goat anti-mouse IgG antibody were both from Sigma-Aldrich.

Cell culture

Normal human PASMCs were acquired from the American Type Culture Collection (PCS-100-023; ATCC, Mannassas, VA, USA. We subcultured the cells, and cells at the 4th to 9th passages were used in our experiments. The medium was composed of high glucose Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine serum (FBS) and 1% penicillin or streptomycin at 37°C, in a humidified incubator with 5% CO2. After being conventionally cultured for 48 h, the cells were serum-starved for 24 h in serum-free medium. The control group consisted of cells cultured with no special treatment for the next 24 h, whereas the hypoxia group was cultured in with serum-free medium with 50 µM CoCl2, and the treatment groups were treated with various concentrations (0.1, 1, 10 and 100 µM) of Sp for 40 min prior to the induction of hypoxia.

Cell viability assay

Cell viability was measured using a Cell Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan). The PASMCs were seeded in 96-well plates at a density of 3×103 cells/well. After being serum-starved for 24 h, various concentrations of CoCl2 (10, 25, 50, 100, 300, 600 and 1,000 µM) were added to the medium and the cells were cultured for 6, 12 and 24 h, respectively. We then used a microplate spectrophotometer (BMG LABTECH, Offenburg, Germany) to detect the optical density (OD) at 450 nm (A450).

Cell proliferation assay

PASMC proliferation was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, CCK-8 assay and BrdU incorporation assay. For MTT assay, the cells were seeded in 96-well plates at a density of 1×103 cells/well. The proliferation of the PASMCs in the control, hypoxia and treatment groups was measured. The operating protocols were according to the instructions provided by the manufacturer of the MTT kit (Boster Institute of Biotechnology, Wuhan, China). The absorbance [optical density (OD)] at 490 nm (A490) was measured using a microplate spectrophotometer.

For CCK-8 assay, the cells were seeded in 96-well plates at a density of 3×103 cells/well. At the end of the treatment period, 10 µl CCK-8 was added to each well followed by incubation for 1.5 h at 37°C. Subsequently, we detected the OD value at 450 nm (A450) using a microplate spectrophotometer.

For BrdU incorporation assay, the cells were seeded in 12-well plates at a density of 3×104 cells/well. BrdU was incorporated in proliferating cells according to the manufacturer's instructions (Roche Diagnostics GmbH). For evaluation by fluorescence microscopy (Nikon Corp., Tokyo, Japan), we used an excitation wavelength in the range of 450–500 nm and detection in the range of 515–565 nm.

Cell cycle analysis

In the present study, cell cycle progression was determined by flow cytometry. The cells were harvested with 0.25 g/l trypsin in 6-well plates, re-suspended in 10 ml PBS, 1 ml 70% ethanol was added, and the cells were then centrifuged (2,000 rpm, 5 min, 4°C) and washed with cold PBS. The cells were subsequently dyed with 100 µl RNAse (1 mg/ml) and then 400 µl PI (20 µg/ml). Following incubation for 30 min at room temperature, the samples were run on a 7 Laser SORP BD LSR II system (BD Biosciences, Franklin Lakes, NJ, USA) and the data was analyzed using CellQuest software (BD Biosciences).

Western blot analysis

The cells were harvested and then lysed. Equal amounts of proteins were boiled and separated with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrophoretically transferred to nitrocellulose membranes. Equal amounts of proteins were loaded into each lane of a 10% SDS-PAGE gel, electrophoresed and transferred onto membranes. The membranes were blocked with Tris-buffered saline (TBS) containing 5% non-fat milk at room temperature for 1 h, and then incubated overnight at 4°C with the primary antibodies. The primary antibody dilutions were as follows: 1:1,000 for ODC, SSAT, cyclin D1, p27, phosphorylated (p-) or total ERK, PI3K, AKT and 1:10,000 for β-actin. The membranes were incubated in TBST solution with alkaline phosphatase-labeled secondary antibody (diluted 1:5,000) for 1 h at room temperature on a shaker. Finally, antibody-antigen complexes were detected using Western Blue Stabilized Substrate (Promega, Madison, WI, USA) for alkaline phosphatase. The intensities of the protein bands were quantified using a Bio-Rad ChemiDoc™ EQ densitometer and Bio-Rad Quantity One software (Bio-Rad Laboratories, Hercules, CA, USA).

Statistical analysis

All data are expressed as the means ± SE and represent at least 3 independent experiments. Statistical comparisons were made using a paired or unpaired t-test, and one-way analysis of variance (ANOVA). A p-value <0.05 was considered to indicate a statistically significant difference.

Results

Effect of CoCl2 on PASMC viability

The results of the CCK-8 assay indicated that the number of PASMCs firstly increased and then decreased in a concentration and time-dependent manner. The cells incubated in control medium were considered 100% viable. CoCl2 at a concentration of 10–100 µM increased the proliferation of the PASMCs, and this trend was particularly evident when the cells were incubated with 50 µM CoCl2 for 24 h; however, when the cells were incubated with CoCl2 at a concentration of 300–1,000 µM, the number of viable PASMCs notably decreased (Fig. 1).

Figure 1

Effect of various concentrations of CoCl2 and treatment times on the number of pulmonary artery smooth muscle cells (PASMCs). The number of PASMCs was detected by CCK-8 assay. The number of cells increased at a concentration of 10–100 µM, and decreased at a concentration of 300–1,000 µM in a time-dependent manner. The cells incubated with control medium were considered 100% viable. Data are presented as the means ± SEM of 8 determinations.

Changes to the key regulatory enzyme of polyamine metabolism under hypoxic conditions

ODC is an enzyme that performs the first step in polyamine biosynthesis; SSAT is the key regulatory enzyme for polyamine catabolism (13,14). Compared with the control group, the expression of ODC was decreased and that of SSAT was significantly increased in the hypoxia groups (p<0.05). These results indicated that hypoxia induced a decrease in endogenous Sp (Fig. 2).

Figure 2

Changes to the key regulatory enzyme for polyamine metabolism under hypoxic conditions. The level of endogenous spermine (Sp) was reflected by the protein expression of (A) ornithine decarboxylase (ODC) and (B) spermidine/spermine N1-acetyltransferase (SSAT). These were examined using western blot analysis. The intensity of each band was quantified by densitometry, and data were normalized to β-actin. *p<0.05 vs. control group. All data are representative of 4 independent experiments.

Exogenous Sp inhibits the increase in PASMC proliferation caused by chemically-induced hypoxia

To demonstrate the effect of Sp on PASMC proliferation, cell viability was examined by MTT assay (Fig. 3A). We found that exposure to chemically induced hypoxia for 24 h significantly promoted PASMC proliferation. At a concentration of 1 and 10 µM, Sp inhibited PASMC proliferation compared with the hypoxia group (p<0.05); however, Sp at 0.1 and 100 µM had no significant effect on PASMC proliferation under hypoxic conditions (p>0.05). The CCK-8 assay demonstrated similar results (Fig. 3B). To assess the population of actively synthesizing DNA cells, a BrdU assay was utilized. The fluorescence intensity of DNA reflects the ability of cells to proliferate. Our results revealed that the induction of hypoxia markedly increased cell proliferation compared with the control group (p<0.05). Sp at 1 and 10 µM inhibited PASMC proliferation compared with the hypoxia group (p<0.05); however, the effect of Sp at 0.1 and 100 µM was not significant (p>0.05; Fig. 3C).

Figure 3

Exogenous spermine (Sp) inhibits chemical hypoxia-induced pulmonary artery smooth muscle cell (PASMC) proliferation. The effects of Sp on PASMC proliferation were analyzed by measuring the optical density (OD) in (A) MTT assay, (B) CCK 8 assay, and (C) the fluorescence intensity of DNA by BrdU incorporation assay. *p<0.05 vs. control group; #p<0.05 vs. hypoxia group. Data are represented as the means ± SEM of 8 determinations. H, hypoxia

Exogenous Sp arrests PASMCs at the G1/G0 phase under hypoxic conditions

The cell cycle transition from the G1/G0 phase to the G2/S phase reflects cell proliferation. Therefore, we wished to determine whether Sp affects the cell cycle of PASMCs under hypoxic conditions. As shown in Fig. 4, the exposure of the PASMCs to hypoxia for 24 h caused the cells to enter mitosis. Hypoxia also increased the number of PASMCs in the G2/S phase and decreased the number of PASMCs in the G0/G1 phase (p<0.05). However, treatment with Sp at 1 and 10 µM weakened the effects of hypoxia on the PASMC cell cycle (p<0.05), although Sp at 0.1 and 100 µM did not markedly affect the cycle (p>0.05).

Figure 4

Exogenous spermine (Sp) arrests pulmonary artery smooth muscle cells (PASMCs) in G1/G0 phase under hypoxic conditions. (A) Representative cell cycle histograms measured by flow cytometry. (B) Effects of Sp on the cell cycle of PASMCs. *p<0.05 vs. control group; #p<0.05 vs. hypoxia group. Data are represented as the means ± SEM from 3 experiments. H, hypoxia.

Exogenous Sp affects the protein expression of cyclin D1 and p27 in cultured PASMCs

The expression of cyclin D1 was increased and that of p27 was decreased in the hypoxia group (p<0.05 vs. control group). Compared with the hypoxia group, treatment with Sp at 1 and 10 µM significantly decreased cyclin D1 expression, and increased p27 expression (p<0.05); however, Sp at 0.1 and 100 µM did not have a significant effect (p>0.05; Fig. 5).

Figure 5

Exogenous spermine affects the protein expression of cyclin D1 and p27 in cultured pulmonary artery smooth muscle cells (PASMCs). The expression of (A) cyclin D1 and (B) p27 was examined by western blot analysis. The intensity of each band was quantified by densitometry, and data were normalized to β-actin. *p<0.05 vs. control group; #p<0.05 vs. hypoxia group. All data were from 4 independent experiments. Sp, spermine; H, hypoxia.

Protein expression of p-ERK, p-PI3K and p-AKT in cultured PASMCs

Compared with the control group, the induction of hypoxia promoted the phosphorylation of ERK1/2 (Fig. 6A) and increased PI3K and AKT phosphorylation (Fig. 6B and C). Treatment with Sp at 1 and 10 µM reversed the effects of hypoxia on the MAPK and PI3K-AKT pathways (p<0.05); however, Sp at 0.1 and 100 µM was not so effective at reducing the effects of hypoxia (p>0.05). The total amount of ERK1/2, PI3K and AKT proteins was not significantly altered in the different groups.

Figure 6

Protein expression of phosphorylated (p-)extracellular signal-regulated kinase 1/2 (ERK1/2), p-PI3K and p-AKT in cultured pulmonary artery smooth muscle cells (PASMCs). The expression of (A) p-ERK1/2, (B) p-PI3K and (C) p-AKT was examined by western blot analysis. The intensity of each band was quantified by densitometry, and data were normalized to total ERK1/2, PI3K and AKT signal. *p<0.05 vs. control group; #p<0.05 vs. hypoxia group. All data are from 4 independent experiments.

Discussion

HPH, a chronic progressive disease with a poor prognosis, is characterized by pulmonary vascular remodeling and a persistent increase in arterial pressure (15). To explore the mechanisms responsible for the development of HPH and to effectively treat this condition, clinical observations and animal experiments are commonly performed. In previous studies using cell models, injury caused by chemically-induced hypoxia was used to construct HPH models (16,17). CoCl2 is a well-known hypoxia mimetic agent that mimics the hypoxic response in many aspects (12). In the present study, we examined the effects of CoCl2 at various concentrations and treatment times on the number of viable PASMCs, and we selected the concentration of 50 µM for 24 h to establish the cell model of hypoxia, as was done in a previous study (18).

Pulmonary arterial remodeling occurs primarily due to the abnormal proliferation of PASMCs (2,3). Therefore, the inhibition of hypoxia-induced PASMC proliferation exerts anti-remodeling effects. The exact mechanisms responsible for pulmonary arterial remodeling have, however, not been fully elucidated thus far, although certain studies have demonstrated that biologically active media, such as endothelin, vascular endothelial growth factor, nitric oxide, prostacyclin and other factors are involved in this pathological process (19,20). Moreover, the association between pulmonary vascular remodeling and polyamine metabolism has not been investigated to date, to the best of our knowledge.

Polyamines, including Sp, spermidine and putrescine, are non-protein small molecules with polyvalent positive charges and nitrogen. Sp, with four positive charges, has the most prominent biological effect (10,21). Polyamines and their metabolic enzymes play an essential role in a number of normal and pathological processes. ODC and SSAT are involved in the regulation of polyamine metabolism (11). The transcription and translation of ODC promote cell growth and differentiation (13). SSAT is the central molecular regulator of polyamine metabolism (14,22). Polyamine catabolism plays an important role in apoptosis and drug and stress responses, and is involved in the etiology of certain pathological conditions (including cancer) (23). It is not yet clear, however, whether hypoxia, as a type of stress, induces disrupts polyamine metabolism. The results of the present study indicated that chemically-induced hypoxia caused a decrease in ODC expression and an increase in SSAT expression in PASMCs. As is known, ODC is one of the main enzymes involved in polyamine biosynthesis, and SSAT is a key enzyme in the terminal degradation of polyamine. Our results suggest that chemically-induced hypoxia causes a decrease in endogenous Sp.

In this study, to examine the effects of Sp on PASMC proliferation, cell viability was measured by MTT assay, CCK-8 assay and BrdU incorporation assay. Our results demonstrated that chemically-induced hypoxia significantly promoted PASMC proliferation and affected the key enzymes involved in polyamine metabolism, ODC and SSAT. Our data also demonstrated that treatment with exogenous Sp (1 and 10 µM) inhibited PASMC proliferation.

Cell division consists of two consecutive processes, which are divided into two stages: mitosis (M), the process of nuclear division, and interphase, the interlude between two M phases. In addition, the stages of interphase include the G1, S and G2 phases. The G1, S, G2 and M phases are the traditional subdivisions of the standard cell cycle. Cells in the G1 phase, before commitment to DNA replication, enter into a resting state termed G0. Cells in the G0 phase account for the major part of the non-growing, non-proliferating cells in the human body (24). The cell cycle, a key therapeutic target in vascular proliferation-associated diseases, is determined by CDK and CDK inhibitors (CDKIs). Cyclin D1 has previously been recognized as a proto-oncogene, whose main role is to promote cell proliferation (25). Cell growth begins at the G1 phase of the cell cycle, and cyclin D1 is a key protein that regulates the cell cycle in the G1 phase. As one of the main CDK inhibitors, p27 has been previously studied in relation to its modulation of PASMC proliferation during mitogenic stimulation, and its overexpression decreases PASMC proliferation (26). Certain studies have suggested that polyamines affect cell cycle progression by regulating proteins, such as cyclins, CDKs and CDKIs (27,28). In the present study, we examined the effects of chemically-induced hypoxia and exogenous Sp on the cell cycle, and on the expression of cyclin D1 and p27. Our results demonstrated that hypoxia promoted the entry of the PASMCs into mitosis by increasing the number of PASMCs in the G2/S phase, decreased the protein expression level of p27 and enhanced the expression of cyclin D1. More importantly, we found that exogenous Sp at 1 and 10 µM reversed the effects of hypoxia on the cell cycle and the expression of related proteins. Therefore, the effects of exogenous Sp are an important mechanism with which to inhibit the proliferation of PASMCs.

ERK1/2 is the most important member of the MAPK family, and can be activated by a variety of extracellular signals, such as ischemia, hypoxia and hormones. ERK1/2 regulates the expression of genes involved in cell growth, proliferation, differentiation and apoptosis (29). Liu et al demonstrated that ERK1/2 induced PASMC proliferation, possibly by increasing cyclin D1 expression and promoting the DNA-binding transcription factor early growth response 1 (Egr-1) and GATA binding protein 4 (GATA-4) (30). Protein kinase B (PKB or AKT) is a major factor of the PI3K signaling pathway. PI3K-AKT signaling pathways regulate cell proliferation, differentiation, survival, migration and other features (31). Previously, it has been reported that PI3K-AKT is associated with PASMC proliferation (8,9,32). In a rat model of pulmonary hypertension, the p-AKT level was shown to be considerably increased, and this was accompanied by the downregulation of p53 and p27 and the upregulation of cyclin D1 expression (33). In the present study, we found that hypoxia promoted the expression of p-ERK1/2, p-PI3K and p-AKT, and that Sp at 1 and 10 µM prevented the effects of hypoxia on the MAPK and PI3K-AKT pathways.

In conclusion, in the present study, we firstly found that hypoxia caused polyamine metabolic disorder and human PASMC proliferation, and exogenous Sp at 1 and 10 µM inhibited the increase in PASMC proliferation caused by chemically-induced hypoxia via the suppression of the ERK1/2- and PI3K/AKT-associated pathways. As lower (0.1 µM) or higher (100 µM) concentrations of Sp did not have a significant effect, which may be related to the inbalance of polyamine metabolism, further studies are warranted to investigate this matter. It is thus suggested that Sp may serve as a novel, specific and attractive therapeutic agent for the treatment of HPH (Fig. 7).

Figure 7

Hypothetical schema outlining the mechanisms through which exogenous spermine inhibites the proliferation of pulmonary artery smooth muscle cells (PASMCs). Exogenous spermine at concentrations of 1 and 10 µM inhibited the of proliferation PASMCs caused by chemically-induced hypoxia via the suppression of extracellular signal-regulated kinase 1/2 (ERK1/2) and phosphatidylinositol 3-kinase (PI3K)/AKT-associated pathways.